Загрузка...
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment
Pneumonitis is a rare but serious adverse event caused by cancer immunotherapy. The diagnosis between COVID-19-induced pneumonia and immunotherapy-induced pneumonitis may be challenging in the era of COVID-19 outbreak. Some clinical symptoms and radiological findings of pneumonitis can be attributed...
Сохранить в:
| Опубликовано в: : | J Immunother Cancer |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7387312/ https://ncbi.nlm.nih.gov/pubmed/32699182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000952 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|